LICENSE GRANT 2 Sample Clauses

LICENSE GRANT 2. 1. Subject to your compliance with the terms and conditions of this Agreement, Seasonal grants you, a non-exclusive, non-transferable, personal, royalty- free, non-commercial license to use the Software, in executable code form only, on one Device (“License”). 2.2. The foregoing is not intended to prohibit you from installing and backing-up the Software for Le présent contrat (le « contrat ») porte sur une licence limitée, personnelle et non commerciale que, à titre de concédant de licence, Seasonal Specialties, Inc. (« Seasonal », « we »), dont le siège social se trouve au 00000, Xxxxxx Xxxx Xxxx, Xxxx Xxxxxxx, XX, XXX 00000, vous accorde (que vous soyez une personne physique ou morale) (le « titulaire de licence », « vous » ou « votre») et qui vous permet d’utiliser l’application logicielle App Controlled Lights (le “« logiciel » ou l’« application »). EN TÉLÉCHARGEANT, EN INSTALLANT OU EN UTILISANT CETTE APPLICATION POUR ANDROID, IOS OU UNE AUTRE PLATEFORME MOBILE, VOUS ACCEPTEZ D’ÊTRE LIÉ PAR LE PRÉSENT CONTRAT. CELUI-CI CONTIENT UNE RENONCIATION DE PARTICIPER À UN RECOURS COLLECTIF (À LA CLAUSE 9) QUI, EN CAS DE DIFFÉREND, A UNE INCIDENCE SUR VOS DROITS EN VERTU DU PRÉSENT CONTRAT. SI VOUS N’ACCEPTEZ PAS LE PRÉSENT CONTRAT, N’UTILISEZ PAS L’APPLICATION. 1. DÉFINITIONS En plus de termes xxxxxxx ailleurs dans le présent contrat, les définitions suivantes s‘appliquent au présent contrat, sous la forme singulière ou plurielle, selon le contexte. 1.1. « appareil » désigne un Android, un iPhone, un iPad ou un autre appareil mobile similaire qui prend en charge le logiciel. 1.2. « documentation » désigne les manuels d’utilisation fournis avec l’application sous forme électronique (notamment les fichiers d’aide en ligne) ou en format papier. 1.3. « date d’entrée en vigueur» désigne l’horodatage (jour et heure) produit par l’ordinateur au moment où vous avez cliqué sur « J’ACCEPTE ». 1.4. « droits de propriété intellectuelle » désigne tous les droits d’auteur, marques de commerce (déposées ou non), secrets commerciaux, brevets, demandes de brevet, savoir-faire, droits moraux et autres droits de propriété mondiaux connus ou existants. 2.
Sample 1
AutoNDA by SimpleDocs
LICENSE GRANT 2. 1 Subject to the terms and conditions of this Agreement, Licensor hereby grants to Licensee and its Affiliates, and Licensee and its Affiliates hereby accept from Licensor, a non- exclusive, nontransferable, royalty-free, fully paid-up license to use both the Software and any Software Changes in executable code form during the Term within the United States. 2.2 Licensor shall continue to own all right, title, and interest in and to the Software, the Software Changes, and all Intellectual Property Rights embodied therein or related thereto, including, but not limited to, the source and executable codes. Except as expressly provided herein, Licensor grants no Intellectual Property Rights to Licensee or its Affiliates by implication, estoppel, or otherwise. 2.3 Licensee shall safeguard the Software and Software Changes and its related materials with that degree of care as is exercised by other similarly situated financial institutions such that no unauthorized use is made of the Software, Software Changes, or related materials and no disclosure of any part of their contents is made to anyone other than Licensee’s Representatives whose duties reasonably require such disclosure, or, as otherwise reasonably necessary in the ordinary course of Licensee’s business. Licensee shall make its Representatives fully aware of their responsibility to fulfill the obligations of Licensee under this Agreement. 2.4 During the Term, Licensor may, at its sole discretion, provide Updates to or Upgrades of the Software. Licensor shall, from time to time, update the Software to improve basic functionality, security, and responsiveness and ensure that the Software provides at least industry-standard functionality, security, and responsiveness. Licensor anticipates that a minimum of two such updates per year will be required to ensure that Licensee continues running a current version of the Software. Unless otherwise agreed in writing by the parties, Licensor shall not charge, and Licensee shall not be responsible to pay, any additional fees, costs, or expenses for Updates, Upgrades, or other Software Changes made by Licensor. In no event shall Licensor materially degrade the functionality, responsiveness, or security of the Software. 3.
Sample 1
LICENSE GRANT 2. 1 CPVD grants to IDM Group a nonexclusive, worldwide, royalty-bearing license, under the LICENSED PATENTS, to manufacture, have manufactured, use, and sell LICENSED PRODUCTS.
Sample 1
LICENSE GRANT 2. 1. Subject to the limitations set forth in this Agreement, Rutgers hereby grants to Licensee: *** Indicates the omission of confidential material pursuant to the request for confidential treatment made in accordance with Rule 24b-2 under the Securities Exchange Act of 1934, as amended. The confidential material is being filed separately with the Securities and Exchange Commission. 9
Sample 1
LICENSE GRANT 2. 1. Subject to full and timely payment of all amounts owed or due to XXXX under this Agreement and the other terms, conditions, and limitations hereof, XXXX grants you the non-transferable and non-exclusive license (a) to install and use the Software up to the Authorized Use, solely for your own internal personal or business purposes and in accordance with the Documentation; (b) make a single copy of the Software solely for archival purposes; and (c) store or install a copy of the Software on a storage device such as a network server, used only to install or run the Software on your other computers on an internal network, provided (unless you are licensing on an individual named-user basis) that you acquire and dedicate a separate license for each separate computer/device on which the Software is installed, run or otherwise accessed from the storage device. A single license for the Software does not allow you to share the Software or use it concurrently on different computers/devices.
Sample 1
LICENSE GRANT 2. 1 Nonexclusive License Subject to the terms hereof, as of the Effective Date and for the License Term, BUTAMAX hereby grants to HIGHWATER a limited, revocable, nonexclusive license under BUTAMAX Intellectual Property, to (i) use, demonstrate at BUTAMAX’s direction, and operate the Project Nemo Facility solely at the Plant, within the Field of Use; and (ii) make, use, offer or market for sale and sell Product only within the Field of Use. The BUTAMAX license granted herein is contingent upon the Parties’ execution of each of the Butamax Agreements. 2.2 This license is non-sublicensable, non-transferable, and subject to the Security Agreement and shall apply (unless terminated prior to expiration and/or HIGHWATER is in breach of this or any Definitive Agreement) only while HIGHWATER is producing: 1) ethanol or *** 2.3 BUTAMAX is and shall remain the sole and absolute owner of the Technical Information, the LTP, all BUTAMAX Intellectual Property and BUTAMAX Confidential Information, including its technology and any improvements thereto, and including Improvements and Inventions as defined below. 2.4 Improvements Should BUTAMAX further develop or improve the BUTAMAX Intellectual Property (licensed hereunder) during the Payment Term, BUTAMAX will offer to HIGHWATER pursuant to a separate license agreement or by amendment to this License Agreement, without additional requirement for Payment, a nonexclusive license to use, limited to the Field of Use and the restrictions set forth in Section 2.1 and 2.2, (i) such improvements that are the result of activities at the Plant demonstrating the use and operation of the Butamax Unit; or (ii) such improvements developed as a result of activities by BUTAMAX or BUTAMAX Affiliate utilizing the Butamax Unit; in each case, to the extent such improvements or developments (a) may provide an increase in corn oil production or quality, and/or (b) reduction in operating costs and/or improvements to the Plant or Butamax Unit efficiencies, (excluding any equipment to be provided by a third party, third party intellectual property, or any potential enzyme development activity by a third party or other party not under BUTAMAX’s control) (“Improvements”). BUTAMAX’s obligation to offer Improvements for license as provided in this paragraph 2.4, is only in effect while HIGHWATER is in compliance with all the terms and conditions of the Definitive Agreements. Any costs or fees associated with implementing any Improvements are HIGHWATER’s...
Sample 1
LICENSE GRANT 2. 1 As of May 29, 1998, Wyeth hereby grants DOV an exclusive license under Wyeth Patents and Wyeth Know-How to make, have made, use, and/or sell Marketed Product in the Territory. 2.2 Subject to Wyeth's right of first refusal provided for in Article 4.0 and the provisions in Article 5.0, DOV shall have the right to grant sublicenses under the License provided for in Article 2.1. 5 <PAGE> ARTICLE 3.0
Sample 1
AutoNDA by SimpleDocs
LICENSE GRANT 2 
Sample 1

Related to LICENSE GRANT 2

  • License Grant If Products include software, firmware or documentation, Supplier grants to DXC a non-exclusive, perpetual, royalty free, worldwide license to use, reproduce, display, prepare derivative works of the documentation and distribute such works, software, firmware or documentation directly or as integrated into DXC products, and to sublicense such rights to third parties. Supplier shall identify all licenses and deliver to DXC all materials required to meet the requirements of any licenses for third party software that is included in the Products. Supplier shall deliver to DXC the source code for any software licensed under a license that has a source availability requirement (such as the GNU General Public License). If the source code is not included with the material that Supplier has previously delivered, Supplier shall deliver within seven (7) days after DXC’s request the source code for any software licensed under an open source license that has a source availability requirement. Supplier grants DXC the right to duplicate and distribute the materials as necessary.

  • Sublicense Grant Licensee will be entitled to grant Sublicenses to third parties under the license granted pursuant to Section 2.1 subject to the terms of this Section 2.3. Any such Sublicense shall be on terms and conditions in compliance with and not inconsistent with the terms of this Agreement. The grant of a Sublicense shall not in any way diminish or alter Licensee’s obligations under this Agreement.

  • License Grants The licenses granted in this Section 2 are subject to the terms and conditions set forth in this XXXX:

  • Exclusive License Grant Subject to the terms and conditions of this Agreement (including Section 3.5.1 (Takeda Retained Rights)), Takeda hereby grants to Licensee an exclusive, sublicensable (subject to Section 3.3 (Sublicensing)), royalty-bearing right and license under the Takeda Technology and Takeda’s interest in the Joint Technology to Exploit the Licensed Compounds and Licensed Products in the Field in the Licensee Territory.

  • Non-Exclusive License Grant In the event that either: (i) the making, have made or use by Merck or its Related Parties of any Cue Biologics during the term of this Agreement; or (ii) the making, having made, use, import, offer for sale and/or sale by Merck or its Related Parties of Compound or Product in the Territory would infringe a claim of an issued letters patent that Company (or its Affiliate) Controls and which patents are not covered by the grant in Section 3.1, Company hereby grants to Merck, to the extent Company is legally able to do so, a non-exclusive, sublicensable, royalty-free license in the Territory under such issued letters patent for Merck and its Related Parties to conduct such activities with respect to the Cue Biologics, Compounds and Products for all activities in the Field.

  • The License 3.1.1 Subject to and in accordance with the terms and conditions set forth in this Agreement, and in particular subject to the due fulfillment of all the obligations assumed towards Maha-Metro by the Licensee, Maha-Metro hereby grants and authorizes the Licensee to the following (the “Specified Purpose”) :

  • Sublicense Rights Licensee shall not have the right to grant sublicenses under the licenses granted to it under Section 2.1(a) (Development and Commercialization License to Licensee) and Section 6.3(d) (Use of Coherus Trademark), without the prior written consent of Coherus, which consent may be withheld [***], except with respect to [***], in which case [***]. For the avoidance of doubt, it shall be [***] with respect to [***]. If Coherus consents in writing to allow Licensee to grant a sublicense, then Licensee may grant such sublicense, through [***], subject to the following: (a) each Sublicensee shall agree to be bound by all of the applicable terms and conditions of this Agreement; (b) the terms of each sublicense granted by Licensee shall provide that the Sublicensee shall be subject to the terms and conditions of this Agreement; (c) Licensee’s grant of any sublicense shall not relieve Licensee from any of its obligations under this Agreement; (d) Licensee shall be liable for any breach of a sublicense by a Sublicensee to the extent that such breach would constitute a breach of this Agreement, and any breach of the sublicense by such Sublicensee shall be deemed a breach of this Agreement by Licensee to the extent that such breach would constitute a breach of this Agreement as if Licensee had committed such breach; provided, however, that in each instance of any breach, Licensee and/or Sublicensee shall have the right to cure any such breach pursuant to the terms of this Agreement; and (e) Licensee will notify Coherus of the identity of any Sublicensee, and the territory in which it has granted such sublicense, promptly after entering into any sublicense. Notwithstanding anything to the contrary in this Agreement, for clarity, Licensee shall not have the right to grant sublicenses under Section 2.1 (License Grants) to any Third Party to Manufacture Products or to conduct Process Development.

  • Sublicense (a) The license granted in Paragraph 2.1 includes the right of LICENSEE to grant Sublicenses to third parties during the Term but only for as long as the license to Patent Rights is exclusive.

  • License Terms This license is for one full Semester. It cannot be cancelled or terminated except under the conditions cited in this license.

  • Sublicensing Rights Novartis and its Affiliates may grant sublicenses of the license granted in Section 5.3.1(a), Section 5.3.2, and Section 5.3.3, and Intellia and its Affiliates may grant sublicenses of the license granted in Section 5.3.1(b), provided that (a) such sublicense (i) is in writing, (ii) is subject and subordinate to, and consistent with, the terms and conditions of this Agreement, and (iii) requires the applicable sublicensee to comply with all applicable terms of this Agreement [***]; (b) with respect to Novartis or any of its Affiliates as the sublicensing Party to the extent required by the Key License Agreements as in effect on the Effective Date or the agreements for any Included Intellia New In-Licensed Intellectual Property, Novartis promptly notifies Intellia of the grant of each sublicense and provides Intellia a copy of the final executed sublicense agreement, redacted for information not pertinent to this Agreement to the extent that such redactions do not reasonably impair Intellia’s ability to ensure compliance with this Agreement, the Key License Agreements or agreements for any Included Intellia New In-Licensed Intellectual Property, as applicable, (c) Novartis or Intellia, as applicable, shall be responsible for the failure by its sublicensees to comply with, and Novartis or Intellia, as applicable, guarantees the compliance by each of its sublicensees with, all relevant restrictions, limitations and obligations in this Agreement, and [***]. CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.

Time is Money Join Law Insider Premium to draft better contracts faster.